MicroRNAs (miRNAs) are a class of small noncoding RNAs involved in posttranscriptional regulation. miRNAs are utilized in organisms ranging from plants to higher mammals, and data have shown that DNA viruses also use this method for host and viral gene regulation. Here, we report the sequencing of the small RNAs in rat cytomegalovirus (RCMV)-infected fibroblasts and persistently infected salivary glands. We identified 24 unique miRNAs that mapped to hairpin structures found within the viral genome. While most miRNAs were detected in both samples, four were detected exclusively in the infected fibroblasts and two were specific for the infected salivary glands. The RCMV miRNAs are distributed across the viral genome on both the positive and negative strands, with clusters of miRNAs at a number of locations, including near viral genes r1 and r111. The RCMV miRNAs have a genomic positional orientation similar to that of the miRNAs described for mouse cytomegalovirus, but they do not share any substantial sequence conservation. Similar to other reported miRNAs, the RCMV miRNAs had considerable variation at their 3 and 5 ends. Interestingly, we found a number of specific examples of differential isoform usage between the fibroblast and salivary gland samples. We determined by real-time PCR that expression of the RCMV miRNA miR-r111.1-2 is highly expressed in the salivary glands and that miR-R87-1 is expressed in most tissues during the acute infection phase. Our study identified the miRNAs expressed by RCMV in vitro and in vivo and demonstrated that expression is tissue specific and associated with a stage of viral infection.
MicroRNAs (miRNAs) are small noncoding RNAs involved in posttranscriptional regulation through binding to complementary sequences in target mRNAs resulting in gene silencing (4) . miRNAs are ubiquitous among multicellular eukaryotic organisms, including plants and higher mammals, and have diverse roles in many different biological processes, including development, differentiation, proliferation, apoptosis, and hematopoiesis (35, 51) . In addition to eukaryotic miRNAs, DNA viruses, mainly of the Herpesvirus family, have been shown to encode miRNAs. Bioinformatic, sequencing, and direct cloning approaches have led to the identification of more than 140 viral miRNAs (reviewed in reference 55). The role of viral miRNAs is proposed to include the targeting of cellular genes to induce a favorable replication environment or to evade the host immune system and the targeting of their own viral genome to regulate viral gene expression during persistence or latency/reactivation (22, 55) .
Human cytomegalovirus (HCMV) is known to encode at least 14 miRNAs. HCMV is a ubiquitous betaherpesvirus, and primary infection results in lifelong persistent/latent infection of the host. Infection of immunocompetent hosts is generally asymptomatic, but infection of immunocompromised hosts can lead to high morbidity and mortality. HCMV has been linked to the development of atherosclerosis, arterial restenosis following angioplasty, and solid-organ transplant vascular sclerosis (TVS) (40, 41, 57) . HCMV infection nearly doubles the 5-year rate of cardiac graft failure due to accelerated TVS (20) and doubles the rate of liver graft loss at 3 years (14, 52) . Since the betaherpesviruses, including HCMV, are highly species specific, effective animal models have been established to investigate the role of CMV infection in chronic disease. We have utilized a rat cytomegalovirus (RCMV) infection system to model a number of human diseases associated with HCMV infections, including solid-organ transplant rejection and restenosis following angioplasty (26, 27, 29-31, 36-39, 45, 46, 56, 58, 62-64) . Similar to human infection, infection of immunocompetent rats leads to a limited subclinical infection that persists lifelong in host bone marrow and columnar epithelial cells of the salivary glands (28) . RCMV infection of immunocompromised rats (i.e., rats undergoing immunosuppressive treatment for the prevention of allograft rejection) leads to infection of most host tissues and organs. We have shown that RCMV gene expression is highly restricted in tissues from allograft recipients following infection. In fact, the highly expressed genes in tissues from the infected rats are hypothesized to be involved in host cell manipulation and/or immune evasion, which allows the virus to persist by turning over small amounts of infectious virus while remaining undetected by the immune system (65) . However, the mechanisms by which CMV controls viral gene expression in vivo are still unknown. Recent studies suggest that miRNAs may play an important role in regulating CMV gene expression and latency (23) . The aim of the present study was to identify the miRNAs encoded in the RCMV genome and determine expression levels in tissue culture-infected fibroblasts, as well as in persistently infected tissues from RCMV-infected heart allograft recipients. Our elucidation of the RCMV miRNAs expressed during lytic and persistent in vivo infections is crucial for our understanding of their role in CMV persistence, pathogenesis, and disease.
MATERIALS AND METHODS

RCMV.
The titers of salivary gland-derived stocks of the Maastricht strain of RCMV were determined using primary rat lung fibroblasts (RFL6 cells) (5, 6) . Plaque assays were performed in confluent 24-well plates by infection with an appropriate serial virus dilution in 0.2 ml of medium and then incubation at 37°C for 90 min. Following incubation, the infected cells were rinsed with phosphatebuffered saline (PBS) and overlaid with 1 ml Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), nonessential amino acids, penicillin-streptomycin, and 20 mM L-glutamine with a final concentration of 0.6% agarose. After 7 days, the cells were fixed in 3.7% formaldehyde in PBS and stained with 0.05% aqueous methylene blue. The plaques were counted by light microscopy.
RCMV infection of tissue culture cells. RFL6 cells were maintained in DMEM supplemented with 10% FCS and penicillin-streptomycin-glutamine (42, 62) . For the cloning and sequencing of the RCMV miRNAs from in vitro-infected cells, RFL6 cells were plated onto 150-mm dishes (Costar). These cells were infected with RCMV upon confluence at a multiplicity of infection (MOI) of 0.1. After 3 h, the cells were washed three times with PBS. The infected cells were harvested at 72 h postinfection (hpi) by one washing with PBS and then addition of 3 ml of Trizol reagent. The reagent was allowed to lyse the cells for 5 min at room temperature. Subsequently, the samples were stored frozen at Ϫ80°C. For miRNA real-time PCR analysis of the RCMV miRNAs miR-R87-1 and miRr111.2-6 in infected tissue culture cells, RFLs were plated into six-well plates. The cells were infected with RCMV (MOI of 0.1) and harvested by addition of Trizol, as described above, at 6, 24, and 48 hpi.
Preparation of rat tissues from heart allograft recipients. To identify the RCMV miRNAs expressed in vivo, we sequenced the small RNAs from total RNA samples isolated from salivary glands from rat allograft recipients at 21 days postinfection (dpi) (62, 65) . Rat heart transplant surgeries were performed as previously described (45, (62) (63) (64) (65) . Various tissues (native and graft heart, salivary gland, spleen, liver, kidney, and lung) were collected from infected heart allograft recipients at 7 and 28 dpi (61, 62, 65) for real-time PCR analysis of the RCMV miRNAs miR-R87-1 and miR-r111.1-2. For each analysis, total RNA was prepared from approximately 0.25 g of rat tissue using the Trizol method. All animals were housed in the Portland VA Medical Center animal facilities in a specific-pathogen-free room. This facility is AAALAC accredited and complies with the requirements for animal care stipulated by the USDA and HHS. miRNA deep sequencing. Deep sequencing was performed by LC Sciences (Houston, TX). Accordingly, for each sample, about 10 g of total RNA was size fractionated on a 15% Tris-borate-EDTA (TBE) urea polyacrylamide gel and a 15-to 50-bp fraction was excised. The small RNA fraction was eluted from the gel slice in 500 l of 0.3 M NaCl and precipitated by the addition of ethanol. According to the Illumina Solexa instructions, both 5Ј and 3Ј RNA adaptors were added using T4 RNA ligase and the ligated RNA was again size fractionated on a 15% TBE polyacrylamide gel. The fraction containing the 65-to 100-bp region was excised from the gel and precipitated. The recovered RNA was converted to single-stranded cDNA using Moloney murine leukemia virus reverse transcriptase (RT) and the Illumina Solexa RT primer. The cDNA was amplified with Pfx DNA polymerase for 20 cycles by PCR using the Illumina Solexa small RNA primer set. PCR products were purified on a 12% polyacrylamide gel, and the 80-to 120-bp fraction was excised from the gel and eluted and precipitated as described above. The samples were resuspended and sequenced using the Illumina Solexa G1 sequencer. Raw sequencing data were filtered for composition, the presence of adaptor dimers, length, sequence repetition, and copy number. The filtered data were then mapped to current miR databases, the Rattus norvegicus genome, and the RCMV genome (AF232689).
Northern blot analysis. Total RNA was isolated from infected (72 hpi) or uninfected rat fibroblasts using the Trizol (Invitrogen) method. To determine the kinetics of RCMV miRNA gene expression, another set of fibroblasts were harvested at 0, 8, 48, and 48 hpi in the presence of foscarnet (1:250 125 mM). Equal volumes of formamide and loading dye were added to each 20-g sample of RNA. The samples were boiled for 5 min and cooled on ice prior to loading onto a 15% urea-acrylamide gel. The gel was transferred to GeneScreen plus (Perkin-Elmer) membrane in 1ϫ TBE. Probes were produced by end labeling oligonucleotides using polynucleotide kinase (Fermentas) with [␥-32 P]dATP. The total labeled probe was hybridized to the blot overnight at 38°C in PerfectHyb Plus (Sigma Aldrich). The blot was washed two times with a lowstringency buffer (2ϫ SSC [1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 0.05% sodium dodecyl sulfate [SDS] ) and one time with a high-stringency buffer (0.1ϫ SSC, 0.1% SDS) at 38°C. The blot was exposed to autoradiographic film (Kodak BioMax MS) overnight at Ϫ80 C.
Quantitative RT-PCR detection of RCMV miRNAs. Real-time RT-PCR was used to quantify the RCMV miRNA expression in RCMV-infected fibroblasts and tissues from RCMV-infected heart allograft recipients. miRNA cDNA was generated from total RNA using the TaqMan microRNA reverse transcription kit (Applied Biosystems) in 15-l reaction mixtures containing 1.5 pmol of the miRNA-specific RT primer and 100 ng of total RNA. The sequences of the miR-R87.1 and miR-r111.1-2 RT primers are GTC GTC TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG ACG AGTT G and GTC GTC TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG ACA CGC CG, respectively. Samples were incubated in an Applied Biosystems 9700 thermocycler at 16°C for 30 min, 42°C for 30 min, and then 85°C for 5 min. Real-time PCR (TaqMan) was used to quantify miRNA levels from 1.5 l of the cDNA reaction mixture run in a ABI StepOnePlus real-time PCR machine using 40 cycles of 95°C for 15 s and 60°C for 1 min (63) (64) (65) . The primer and probe sets used included miR-R87-1 forward primer GCT CGA AGA ACG GGT GC, reverse primer GTG CAG GGT CCG AGG T, and probe TGG ATA CGA CGA GTT G and miR-r111.1-2 forward primer GCT CGA AAC AAC GTG GA, reverse primer GTG CAG GGT CCG AGG T, and probe TGG ATA CGA CAC GCC G. Oligonucleotides with the miRNA sequences for miR-R87-1 and miR-r111.1-2 were used as quantification standards. Data are presented as relative copy numbers per 10 ng of total input RNA. 
RESULTS
Identification of RCMV miRNAs. To identify the miRNAs encoded by RCMV, we deep sequenced the small RNAs expressed in RCMV-infected fibroblasts and in persistently infected salivary glands from a rat infected for 21 days. We have previously demonstrated that salivary glands from rats infected for 21 days have highly restricted viral gene expression profiles, limited to a small number of genes involved in immune evasion and persistence (65) . For sequencing experiments, total RNA was extracted and the small RNAs (15 to 25 bp) were isolated by polyacrylamide gel electrophoresis. The RNAs were ligated to 5Ј and 3Ј primers and deep sequenced using an Illumina Solexa G1 sequencer. The total reads were filtered for composition, length, and junk.
A total of 6,665,287 reads were made in the RCMV-infected fibroblast sample, and nearly 41% of the sequences were mapped to either the cellular miR database or the rat genome (Table 1) . A total of 7,230,718 reads were made in the RCMVinfected salivary gland sample, and nearly 33% of the sequences were mapped to the miR database and/or to the rat genome. Approximately 87% of the sequenced small RNAs from the infected fibroblast sample and 85% from the infected salivary glands were between 19 and 23 bp. A list of the cellular miRNAs detected in the infected fibroblasts and salivary glands is available at http://www.ohsu.edu/vgti/suppdata.htm. Of the 976,611 unmapped sequences from the RCMV-infected fibroblasts 305,522 (31%) mapped to hairpin structures within the RCMV genome. However, the number of sequences mapping to the RCMV genome from the infected salivary gland sample was only 0.7% of the total reads (4,159 total counts). The remainder of the unmapped sequences most likely represent RNA degradation products, noncoding RNAs, or as-yetunrealized cellular miRNAs. We identified 24 unique miRNAs in the RCMV-infected samples (fibroblasts and salivary gland tissue combined) that mapped to hairpin structures found within the viral genome (Table 2 ; http://www.ohsu.edu/vgti/suppdata.htm). Of the 24 RCMV miRNAs, 22 were expressed in the fibroblast sample, with 4 (miR-r1-4, miR-r43.1-2, miR-R90-1, and miR-r111.2-1) being uniquely detected in this sample and not in salivary gland tissue. Twenty viral miRNAs were detected in the salivary glands; 18 of these were also detected in the fibroblasts, and two RCMV-encoded miRNAs (miR-r95.1-1 and miR-r170-1) were only present in the salivary gland tissues. The viral miRNAs ranged from 16 to 23 nucleotides (nt) in length; however, most were between 19 and 22 nt. As expected, the overall viral miRNA copy number in the salivary glands was lower than in the infected fibroblasts, which is most likely due to the lower infection rate found in vivo. Expression profiles (types of miRNAs and relative levels) of the RCMV miRNAs are, for the most part, consistent under both in vitro and in vivo conditions. Accordingly, the most highly expressed of the viral miRNAs, miR-R87-1, miR-r111.1-2, miR-r111.2-5, and miRr1-1, are commonly expressed under both conditions (Table 2) . A small number of RCMV miRNAs are expressed at low levels, and it is possible that their discovery alone might be due to the high sensitivity of the deep sequencing methods employed for this study. To validate the expression of the RCMV miRNAs, we performed Northern blot analysis of RNA extracted from RCMV-infected RFL6 fibroblasts at 72 hpi. Figure 1 shows the results obtained from 16 out of 24 RCMV miRNAs compared to the control cellular miRNA miR-16. We observed the mature form (ϳ22 nt) of all of the miRNAs, as well as the pre-miRNA forms of some of them.
Identification of RCMV miRNA isoforms. Similar to what has been observed in other studies of viral and cellular miRNAs, a number of the RCMV miRNAs had considerable variation at their 3Ј and 5Ј ends. As shown in Table 3 , the variation, for the most part, was conserved between the miRNAs detected in the infected fibroblasts and those in the rat salivary gland tissues. However, there were specific examples where the percentage of the particular miRNA isoform differed between the two samples. For example, RCMV miR-r6-1 has four major isoforms but only three of these were dominant in the fibroblasts. One of the isoforms of miR-r6-1 (TCGAC CTCAAGCCGTTCGGGGACA) was the most highly expressed isoform detected in salivary gland tissues, but this isoform was expressed to very low levels in fibroblasts. Similarly, one of the isoforms of RCMV miR-OriLyt-2 was only detected in the in vivo sample (60% of the sequenced sequences for this miRNA) but not in infected fibroblasts. We also detected the miRNA* (passenger strand) for 13 of the viral miRNAs, and some of these were detected as major isoforms, including those for RCMV miR-r6-1, miR-OriLyt-1, miR-R91-1, and miR-r111.1-1 (Table 3) . RCMV miRNA genomic organization. The genomic positions of the RCMV miRNAs are depicted in Fig. 2 . The RCMV miRNAs are generally distributed across the viral genome. However, similar to what was observed for other herpesviruses, the RCMV miRNAs are often encoded in clusters. The largest cluster of nine viral miRNAs exists in a 700-bp region encoding miR-r111.1-1, miR-r111.1-2, miR-r111.1-3, miR-r111.1-4, miR-r111.2-1, miR-r111.2-2, miR-r111.2-3, miR-r111.2-4, miR-r111.2-5, and miR-r111.2-6. Of these, only two pairs (miR-r111.2-2/miR-r111.2-3 and miR-r111.2-4/miRr111.2-5) are encoded within the same hairpin loop structure (Fig. 3) , indicating that within this region there are at least seven individual hairpin loop structures. A cluster of four viral miRNAs also exists in and near the coding region for the RCMV gene r1, and two of these (miR-r1-2/miR-r1-3) also share a hairpin loop. Six of the RCMV-encoded miRNAs could target RCMV mRNAs because they are directly complementary to RCMV genes, including miR-87-1 (R86), miR-R91-1 (R90), and miR-r170-1 (r164), as well as miR-r111.2-1, miR-r111.2-2, and miR-r111.2-3, which target r111.1. One additional finding that may have implications for viral persistence is the fact that we identified two viral miRNAs expressed from the viral origin of replication, OriLyt.
We compared the miRNA sequences for mouse cytomegalovirus (MCMV) and RCMV using the phylogenetic analysis program Clustal 3.1. There was minimal conservation between the miRNAs from these two related viruses. However, when we compared the genomic positions of the miRNAs for MCMV and RCMV, we observed that most of them had similar orientations in the viral genomes (Fig. 4) . For example, both RCMV and MCMV contain clusters of miRNAs at the extreme 5Ј end of the genome. MCMV contains six miRNAs and RCMV contains four miRNAs in this region. RCMV lacks the MCMV genes (m7 to m22), however; RCMV miR-r6-1 is positioned near R23, which is a location similar to that of the cluster of MCMV miRNAs (m21, m22, and m23). Both viral genomes contain miRNAs in or near OriLyt. While the original description of miR-m59-1, -2, and -3 did not suggest this orientation, further review by our group puts these near the origin of lytic replication. Interestingly, both viruses also contain clusters of miRNAs on complementary strands of the viral genomes in a central region near the RCMV and MCMV 112 open reading frames. This region is close to the large stable intron in MCMV and most likely RCMV, although it has not yet been specifically mapped for this virus. It appears that, as in other CMVs, the locations of the RCMV miRNAs share a genome-wide distribution profile, which is different from the observed clustering of the alpha-and gammaherpesvirus miRNAs in latency-associated regions.
Characterization of RCMV miRNA expression. CMV gene expression in vitro can be divided into three kinetic classes, immediate early (IE), early, and late, based on the requirements of protein synthesis and viral DNA replication. Therefore, we next sought to determine whether the RCMV miRNAs found within the 700-bp region near RCMV r111 are all expressed with the same kinetics or differentially regulated. We performed a Northern blot analysis of RNA isolated from RFL6 fibroblasts infected with RCMV for 8, 24, or 48 h, as well as for 48 h in the presence of foscarnet, which differentiates early from late viral gene expression (65) . Figure 5 demonstrates that miR-r111.1-1 and miR-r111.2-2 and -3 are expressed with early kinetics as their expression was not inhibited by foscarnet treatment. In contrast, miR-r111.1-2 and -3 and miR-r111.2-1 and -4 were expressed with late kinetics since their expression was blocked at late times in the presence of the viral DNA inhibitor.
Since we found that a portion of the RCMV miRNAs were differentially expressed in fibroblasts and salivary glands, we hypothesized that, similar to viral gene expression in tissues (65) , viral miRNA expression is also tissue specific. Therefore, we performed real-time PCR analysis of RCMV miR-R87-1 and miR-r111.1-2 with total RNA prepared from the tissues of rat heart allograft recipients harvested at 7 and 28 days posttransplantation. In infected RFL6 fibroblasts, RCMV miR-R87-1 is expressed at higher levels than miR-r111.1-2 ( Fig.  6A) , which confirmed the sequencing data described above. Similarly, RCMV miR-R87-1 was more highly expressed (by at least 10-fold) than miR-r111.1-2 in tissues from rat heart allograft recipients ( Fig. 6B and C) . Interestingly, miR-R87-1 was expressed to high levels in all tissues except native heart tissue at 7 days posttransplantation, which is the acute phase of infection. In fact, this viral miRNA was most highly expressed in the allograft heart tissue at day 7. However, miR-R87-1 expression was dramatically reduced to undetectable levels at 28 days in allograft heart, spleen, liver, kidney, and lung tissues. The only tissue that expressed miR-R87-1 at 28 days posttransplantation was the salivary gland, albeit at levels that were 7-fold lower than those measured on day 7. RCMV miRr111.1-2 is almost exclusively expressed in salivary gland tissues, and the level of expression increased from day 7 to day 28. Importantly, we have previously shown that viral gene expression profiles are tissue specific and the profiles do not correlate with viral DNA loads or viral mRNA levels (65) .
DISCUSSION
In the present study, we utilized the robust cloning/sequencing approach (2, 32) to identify the miRNAs expressed by the Maastricht strain of RCMV in cultured fibroblasts, as well as salivary glands from infected rats during the persistent phase of infection. Our study differs from previous studies of CMV miRNA identification in that we sequenced the RCMV miRNAs from both acutely infected cells and in vivo persistently infected tissues (7, 15, 16, 21, 47) . We identified 24 small RNAs expressed from the RCMV genome that map to regions predicted to fold into stem-loop structures. In fact, many of the RCMV pre-miRNAs were detected by Northern blot analysis. In addition, we cloned and sequenced the corresponding 0. An additional sample harvested at 48 hpi was treated with Foscavir (foscarnet sodium; 100 mg/ml) to prevent late gene expression. RNA was subjected to Northern blot analysis using probes specific for the predicted RCMV miRNA sequences. Lane 1 (0 hpi) was a mock-infected sample. The values to the left are molecular sizes in nucleotides.
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RCMV-ENCODED miRNAs 385 miRNA* or passenger strand for a number of the miRNAs discovered in this study. Similar to both HCMV and MCMV miRNAs, the RCMV miRNAs are found distributed individually or in clusters across the viral genome, which differs substantially from their distribution in alpha-and gammaherpesviruses (8, 25, 34, 48, 53, 54) . Of the 24 identified RCMV miRNAs, 4 were uniquely detected in the infected fibroblast sample and 2 were unique to the persistently infected salivary gland tissue, which is most likely attributed to the natural variation observed between in vivo and in vitro infection scenarios (65) . The facts that RCMV miR-r111.1-2 was exclusively expressed in salivary glands and its expression increased during persistence whereas miR-R87-1 was downregulated during persistence suggest that viral miRNA expression is dynamic and regulated in vivo. Viral miRNA target discovery and determination of the relevance of this targeting to virus infection have been intrinsically difficult. This problem is compounded for HCMV due to the species specificity of CMVs and the lack of an appropriate in vivo animal model for HCMV. However, various in vitro and bioinformatic studies have identified both cellular and viral targets of the HCMV miRNAs. For example, miR-UL112 targets the viral transcription factor IE protein IE72 and UL114 targets the virally encoded uracil DNA glycosylase, which is important for the transition to late-phase viral DNA replication (13, 23, 60) . A leading hypothesis for the role of miRNAs is in the establishment of latency due to their ability to downregulate IE protein expression especially during the late phase of lytic replication, when the viral miRNAs accumulate to high levels. Subsequently, once latency is established, viral miRNA targeting of the IE genes may help to maintain latency by inhibiting initiation of the lytic cascade. In fact, a common feature of most herpesvirus miRNAs is the targeting of expression of viral transactivators, including the herpes simplex virus type 1 (HSV-1) miR-LAT target ICP0, the Epstein-Barr virus (EBV) miR-BHRF-1 and miR-BART15 targets BZLF1 and BRLF1, respectively, and the Kaposi's sarcoma herpesvirus (KSHV) miR-K10-6-3p targets Rta and Zta (43) . In addition, HCMV miR-US25-1 and miR-US25-2 miRNAs may contribute to the establishment of latency since they were recently shown to reduce viral replication and DNA synthesis of not only HCMV but other DNA viruses as well (HSV-1 and adenovirus) (60) . Thus, it was hypothesized that miR-US25-1 and miR-US25-2 target cellular genes essential for virus growth. Recently, Grey et al. demonstrated that HCMV miR-US25-1 FIG. 6 . RCMV miRNA expression in tissues from RCMV-infected allograft recipients. The level of RCMV miRNA expression was determined by RT-PCR analysis of total RNA samples. Shown are viral miRNA copy numbers determined using dilutions of an oligonucleotide standard with the specific miRNA sequences of miR-R87-1 and miR-r111.1-2. (A) Quantification of RCMV miRNA miR-R87-1 and miR-r111.1-2 expression in RCMV-infected fibroblasts at 0, 6, 24, and 72 hpi. Uninfected cells (time zero) were included as a negative control. Both viral miRNAs accumulate with increasing time. (B) RT-PCR results for RCMV miR-R87-1 from tissues harvested from RCMV-infected heart allograft recipients (n ϭ 3) at 7 and 28 days posttransplantation. RCMV miR-R87-1 was most highly expressed in the allograft heart, spleen, and lung tissues at 7 days posttransplantation. (C) RT-PCR results for RCMV miR-r111.1-2 from tissues harvested from RCMV-infected heart allograft recipients (n ϭ 3). miRr111.1-2 was most highly expressed in salivary glands at 7 and 28 days posttransplantation. ND, not detected.
